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Chemical interactions of mercury species and some
transition and noble metals towards metallothionein
(Zn7MT-2) evaluated using SEC/ICP-MS, RP-HPLC/ESI-MS
and MALDI-TOF-MS†
Ming Xu,a Limin Yanga and Qiuquan Wang*ab
The chemical affinities of three submetallomes (‘‘Mn, Co, Ni, Cu, Cd’’; ‘‘Pd, Pt, Au’’; and ‘‘Hg, CH3Hg,
C2H5Hg-THI’’) towards metallothionein-2 (Zn7MT-2) in a physiological solution environment were
evaluated using SEC/ICP-MS together with RP-HPLC/ESI-IT-MS and MALDI-TOF-MS, and followed the order:
‘‘Zn2+ o Cu2+, Cd2+ 4 Ni2+ 4 Mn2+, Co2+’’; ‘‘Pd2+ 4 Au3+ 4 Pt2+’’; and ‘‘Hg2+ 4 CH3Hg+ 4 C2H5Hg-THI’’.
Besides these, the structural change and composition of the CH3Hg–MT-2 complexes formed during
the CH3Hg
+ titration process were further investigated using CD spectroscopy, RP-HPLC/ESI-MS and
MALDI-TOF-MS, indicating that linear and more hydrophobic (CH3Hg)xMT-2 (x = 12, 13, 14, 15, 16, 17,
18, 19 and 20) were formed. This information is important in understanding the interactions of the
metals with Zn7MT-2 and their corresponding biological functions and toxicities.
Introduction
Most of the elements in the periodic table of the elements can be
found in significant to trace amounts existing as free ions and/or
associated with biomolecules in organisms, regardless of their
beneficial and/or harmful effects. As some of the most important
biomolecules, metalloproteins play a vital role and are a key to
understand biological processes. More than one third of proteins
are metalloproteins, and more proteins are involved with metals
or metalloids for their function.1 The degree of metal binding in
a protein molecule depends on its stereostructure domain site,
which is composed of selective chemical functional groups of the
protein side chains. Theoretically, these stereostructure domain
sites can show different chemical affinities to various metal ions,
and this difference allows metalloproteins to serve in the storage
of metal ions (sometimes for detoxification) and/or as transpor-
ters of them, and in turn the metal ions help the metalloprotein
to accomplish its functions. Research on the binding properties
of a metal towards a protein always provides direct insight into
the molecular mechanisms of the functions of both the metal
and the protein. This kind of research mostly lies in the newly
emerging research field of metallomics.2
Metallothioneins (MTs) are a super family of cysteine-rich
and low molecular weight proteins. They were discovered over
50 years ago and have been identified in bacteria, fungi, algae,
plants, crustaceans and fishes to mammals, exhibiting an
obvious evolutionary relationship.3–5 The expression of MTs in
organisms is generally considered as a biomarker for detoxifica-
tion in response to heavy metals, free radicals and oxidative
agents. For mammals, the MTs consist of, in general, approxi-
mately 60 amino acid residues, and contain two metal-binding
domains: the a domain (eleven cysteine residues) and the
b domain (nine cysteine residues). There are no disulfides,
aromatic amino acids or histidine in the molecules. The extra-
ordinary reactivity of the sulfhydryl group (–SH) in cysteine
residues allows MTs to be involved in the regulation of physio-
logical metals (e.g. Zn) and provides protection against other
adventitious toxic metals and their corresponding species.
Toxic metals may replace the Zn in the MTs, and induce the
formation of more MTs for the deactivation of the toxic metals.6
The binding properties of MTs to metal/metalloid elements
such as Zn, Cd, Cu, Hg, Bi and As have been studied, focusing
on the metalation and demetalation of MTs based on the use of
UV-vis absorption and circular dichroism (CD) spectroscopies
as well as electrospray ionization mass spectrometry (ESI-MS).
These optical spectroscopic and ESI-MS studies have provided
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information on binding site geometric changes as a function of
metal loading and/or structural changes that occurred in the MTs
themselves induced by metalation.7 In this study, an element-
specific detection technique (inductively coupled plasma mass
spectrometry, ICP-MS) coupled with a gentle separation technique
(size-exclusion chromatography, SEC) together with RP-HPLC/
ESI-MS and MALDI-TOF-MS as well as CD spectroscopy, which
provide information on chemical composition and structural
changes of MTs,7–10 were used to study the chemical interactions
of some metallic species with a typical MT, Zn7MT-2 (Zn-induced
from rabbit liver). The unique features of ICP-MS, for example,
multi-element determination ability with high selectivity and sensi-
tivity, allowed us to perform a high-throughput evaluation of the
interaction between Zn7MT-2 and metallic species in a physiological
solution environment. The chemical affinity and binding process of
three submetallomes [‘‘Mn, Co, Ni, Cu, Cd’’; ‘‘Pd, Pt, Au’’; and
especially ‘‘Hg, methylmercury (CH3Hg) and thimerosal (C2H5Hg-
THI)’’] towards Zn7MT-2 (Fig. 1) were evaluated in this study.
Experimental
Reagents
Zn7MT-2 (490%, from rabbit liver) was purchased from Hunan
Lugu Biotechnology Co., Ltd. China, as a dry powder stored at
20 1C, and its solution (0.76 mmol L1) was freshly prepared
before each experiment with buffer solution (10 mM Tris-HCl,
pH 7.4). Methylmercuric chloride (CH3HgCl, 98.5%) obtained
from Dr Ehrenstorfer GmbH, Germany, and ethylmercurithio-
salicylate (C2H5Hg-THI, 98%) from Shanghai Sangon Biological
Engineering Technology and Service Co., Ltd. China, were used to
prepare their stock solutions (1000 mg mL1). Stock Hg solution
(1007 mg mL1 in 9.2% HNO3) was purchased from Sigma-Aldrich
(Saint Louis, Missouri). The standard solutions of Mn, Co, Ni, Cu,
Cd, Pd, Pt and Au were all prepared by dissolving their inorganic
chlorides (498%) in nitric acid (GR grade, 65%, Merck, Darmstadt,
Germany). All of these standard solutions (1000 mg mL1 in 2%
HNO3) were stored in Teflon bottles before use. Other reagents
used were at least of analytical-reagent or higher available purity
grade. Ultra-pure water (18.2 MO cm, Pen-Tung Sah Micro-Electro-
Mechanical Systems Research Center of Xiamen University, China)
degassed by nitrogen gas was used throughout this study.
Instrumentation
Elemental analysis was performed on an ELAN DRC II ICP-MS
(PerkinElmer, SCIEX, Canada), in which DRC stands for
dynamic reaction cell. The ICP-MS was equipped with an
integral peristaltic pump, a concentric pneumatic nebulizer,
and a cyclonic spray chamber. O2 (99.999%) used as a reaction
gas was purchased from Beijing AP Beifen Gases Industry Co.
(Beijing, China). Sulfur determination was achieved by intro-
ducing O2 into the DRC to form
32S16O+ instead of monitoring
32S+, thus eliminating the strong spectral interferences such as
16O2
+. Chromatographic separation of the free metal ions and
their complexes with MT-2 was carried out on a SERIES 200 HPLC
system (PerkinElmer, SCIEX, Canada) equipped with an auto-
sampler, a vacuum degasser and a 200 mL sample loop as well as
a size exclusion column (Superdex 75 10/300 GL, 300  10 mm
I.D., 13 mm, GE Healthcare, Uppsala, Sweden). The chromato-
graphic effluent was directly infused into the ICP-MS after the
SEC separation with a mobile phase containing 5 mM Tris and
100 mM NH4HCO3 (pH 7.4) with a flow rate of 0.75 mL min
1.
For RP-HPLC/ESI-IT-MS analysis, an Agilent 1100 series
chromatographic system (Agilent Technologies, Palo Alto, CA,
USA) was coupled with an Esquire-LC ESI ion trap mass
spectrometer (ESI-IT-MS, Bruker Daltonics, Bremen, Germany).
A VP-ODS C18 column (250  2.0 mm I.D., 5 mm, Shimadzu,
Japan) was used for separation, and a gradient elution program
was set to linearly increase the percentage of mobile phase B
(acetonitrile) from 5% to 80% with a flow rate of 0.15 mL min1
(mobile phase A: ultra-pure water). MALDI-TOF-MS experiments
were performed with a Bruker microflex LRF matrix assisted laser
desorption and ionization time-of-flight mass spectrometer
(Bruker Daltonics, Bremen, Germany). The mass calibrations of
MALDI-TOF-MS were the average of at least 100 shots with the
software provided by the manufacturer using a Peptide and Protein
MALDI-MS Calibration Kit (700 to 66 000 Da, Sigma-Aldrich).
Detailed instrumental setting parameters for the ICP-MS, ESI-
IT-MS and MALDI-TOF-MS systems are listed in Table S1 (ESI†).
The data obtained from these three instruments were analyzed
using the software stations provided by their manufacturers.
CD spectra were acquired on a J-810 spectropolarimeter
(Jasco, Japan) using a 1 mm path length quartz cell for the
near- and far-UV range measurements at room temperature.
The data were collected from 190 to 350 nm using a response
time of 1 s and a scan speed of 100 nm min1. Spectra represent
an average of five scans with the background corrected against
a buffer blank.
Experimental procedures
Analysis of the binding affinities of different metal ions
towards Zn7MT-2. Before use, the Zn7MT-2 standard was firstly
analyzed using SEC/ICP-MS and RP-HPLC/ESI-IT-MS to char-
acterize its chemical composition. For SEC/ICP-MS analysis, the
isotopes of 63Cu, 66Zn, 111Cd and 32S16O were monitored during
analysis. For RP-HPLC/ESI-IT-MS, the RP-HPLC separation was
operated at three pH conditions (pH 3, 5 and 6) by adjusting the
mobile phase with diluted acetic acid and ammonia solutions.
The ESI-IT-MS was set to the positive mode with a scan range
from 50 to 2000 Da.
All chemical reactions were carried out in a buffer solution
(10 mM Tris-HCl, pH 7.4) at 25 1C. For measurements at














































This journal is c The Royal Society of Chemistry 2013 Metallomics, 2013, 5, 855--860 857
different molar ratios of the metal ion to Zn7MT-2, calculated
volumes of each element standard solutions (‘‘Mn, Co, Ni, Cu,
Cd’’ or ‘‘Pd, Pt, Au’’) were mixed together and then added into
Zn7MT-2 solution. After incubation for 1 h at 25 1C, the samples
were analyzed with SEC/ICP-MS. Between each analysis, the
SEC column was eluted with 10 mM EDTA to clean away excess
free metal ions trapped on the column, and then equilibrated with
the mobile phase. The isotopes of 55Mn, 59Co, 60Ni, 63Cu, 66Zn,
111Cd, 106Pd, 195Pt, 197Au and 32S16O were monitored using ICP-MS.
The binding properties of Hg species towards Zn7MT-2.
Again, calculated volumes of Hg species (Hg2+, CH3Hg
+ and
C2H5Hg-THI) were respectively titrated into Zn7MT-2 solution
buffered by 10 mM Tris-HCl (pH 7.4) to obtain different molar
ratios (1, 2, 3, 4, 6, 8, 10, 20, 40, 60, 80 and 100). After
incubation for 1 h at 25 1C, the samples were analyzed with
SEC/ICP-MS, and 66Zn, 202Hg and 32S16O were monitored.
Between each analysis, the SEC column was eluted with 10 mM
EDTA and 0.05% (v/v) 2-mercaptoethanol to clean away the
replaced Zn2+ and excess Hg species, and then equilibrated with
the mobile phase.
For structure analysis, a known volume of CH3Hg
+ solution
was titrated into a 15 mmol L1 Zn7MT-2 solution (10 mM
Tris-HCl, pH 7.4) at room temperature. Through continuous
addition of CH3Hg
+, the CD spectra were scanned at different
molar ratios of CH3Hg
+ to Zn7MT-2 (nCH3Hg+/nMT-2 = 0, 6, 10, 20,
40 and 100). For RP-HPLC/ESI-IT-MS analysis, 20 mL Zn7MT-2
sample titrated with CH3Hg
+ at the molar ratio of nCH3Hg+/nMT-2 = 20
was injected into the column (pH 3). Meanwhile, the same sample
was crystallized with sinapinic acid solution for MALDI-TOF-MS
analysis.
Safety note: mercury species are toxic, and physical exposure to
them during the experimental process should be very carefully
avoided!
Results and discussion
Analysis of Zn7MT-2 with SEC/ICP-MS and RP-HPLC/ESI-IT-MS
In Homo sapiens, there are four kinds of MTs, namely MT-1,
MT-2, MT-3 and MT-4. The most widely expressed MTs in the
human body are MT-1 and MT-2, while MT-3 and MT-4 are
mainly expressed in the central nervous system and stratified
squamous epithelia, respectively.6 Due to the availability of its
commercial products, we selected Zn7MT-2 from rabbit liver as
a model in this study, which has a similar amino acid sequence
and the same 20 cysteine residues as that of humans.
Zn7MT-2 was analyzed using SEC/ICP-MS, and four isotopes
(63Cu, 66Zn, 111Cd and 32S16O) were monitored (Fig. 2). As
expected, this MT-2 standard mainly existed as its Zn form
(492%), and in the chromatogram there are two peaks at
elution times of 15.2–17.0 and 17.0–19.8 min. The first and
second peaks should correspond to the dimer and/or trimer
and monomer of Zn7MT-2, respectively.
11 The same sample was
analyzed in parallel using RP-HPLC/ESI-IT-MS under three pH
conditions (pH 3, 5 and 6). At these pH values (Fig. S1, ESI†),
the molecular weights of the most abundant MT-2 subisoform
(N Ac-MT-2a) were calculated to be 6124.3, 6314.9 and 6569.5 Da,
corresponding to apo-MT-2, Zn3MT-2 and Zn7MT-2, respectively.
In Fig. S1d (ESI†), peaks belonging to subisoforms of rabbit liver
MT-2 can be observed at masses of 870.2 (MT-2a), 874.4 (MT-2c),
876.0 (N Ac-MT-2a), 879.0 (N Ac-MT-2b), 880.3 (N Ac-MT-2c) and
892.5 (N Ac-MT-2e) Da in the mass range of 850–900 Da.12 Other
subisoforms could not be characterized by the ESI-IT-MS used in
this study because of its limited resolution and sensitivity. It
should be noted that the ionization efficiency of the Zn7MT-2
molecule was seriously affected by pH. When the pH approached
near neutral, the total ion signal of MT-2 was remarkably
decreased, and the background in Fig. S1b and c (ESI†) became
complicated due to interference signals. Besides the pH condi-
tions, organic solvent as well as the degree of Zn-metalation of
the MT-2 also influenced the MS signals significantly. We thus
switched to SEC/ICP-MS to study the interactions between metals
and Zn7MT-2 under physiological solution conditions (pH 7.4).
Zinc exchange in Zn7MT-2 by the typical transition and noble
submetallomes evaluated using SEC/ICP-MS
In the toxicity response process, metal substitution in MT molecules
acts as a mechanism of MT-mediated metal detoxification.13 The
Zn2+ in a MT may be replaced by the metal ion which has
the stronger affinity towards the MT, and, in turn, induce the
synthesis of more MTs for deactivation of the metal.6 In order to
compare the interactions between different metals and Zn7MT-2,
the signals of S, Zn and the adventitious metals were monitored
simultaneously using SEC/ICP-MS. As a naturally occurring
element in MT-2 molecules, the number of S atoms (20 in
cysteine and 1 in methionine residues, UniProt: P18055) is
genetically fixed and can be used to represent the MT-2 content.
We could thus monitor the metal ion substitution processes of
Zn2+ in Zn7MT-2 through the ICP-MS intensity ratio of the metal
to S (IM/ISO) in the metal–MT-2 complexes formed, while the
replaced Zn2+ and the excess metal ions were trapped on the SEC.
To validate the reliability of SEC/ICP-MS, the submetallome
selected included five typical transition metals (Mn, Co, Ni, Cu
and Cd) that are essential trace elements, except Cd. From the
viewpoint of bioinorganic coordination chemistry, all these
metal ions can form metal–thiolate bonds with the –SHs in
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apo-MT-2 molecules in vitro. When the MT-2 exists as the
Zn7MT-2 form, obvious replacement of Zn
2+ was observed only
in the case of Cu2+ and Cd2+ but not for Mn2+, Co2+ and Ni2+
(Fig. S2a and b, ESI†). By increasing the molar ratio of the metal
to Zn7MT-2 (nM/nMT-2), Cu
2+ and Cd2+ could progressively
replace more Zn2+ in Zn7MT-2 molecules. For Ni
2+, this sub-
stitution only happened when the molar ratio exceeded one
hundred, indicating that the Zn7MT-2 is relatively thermo-
dynamically stable in a high Ni2+ environment. No obvious
change was observed in the case of Mn2+ and/or Co2+ under our
experimental conditions. The chemical affinities of the metals
(Mn, Co, Ni, Cu, Zn and Cd) to the MT-2 could be thus
concluded as Zn2+ o Cu2+, Cd2+ 4 Ni2+ 4 Mn2+, Co2+. These
results are in accordance with the Irving–Williams series for
divalent metals which is essentially independent of the
ligand,14 suggesting that SEC/ICP-MS is effective for evaluating
the chemical affinities of different metals towards Zn7MT-2.
Noble metals such as Pd, Pt and Au selected in this study are
not in high abundance in ecosystems or organisms, but their
organometallic and/or inorganic compounds are very often
used as anticancer agents, imaging sensors and industrial
catalysts.15,16 These kinds of artificial chemicals bring potential
environmental and health hazards, and therefore have become
an increasing focus of attention.17,18 Fig. S2c and d (ESI†) show
that Zn2+ was replaced remarkably along with an increase in the
molar ratios of Pd2+, Au3+ and Pt2+ to Zn7MT-2. The strong
chemical affinity between these metal ions (Pd2+, Au3+ and Pt2+)
and SHs allowed the replacement of Zn2+ in Zn7MT-2. Based
on these results, Pd2+ seemed to have a stronger affinity than
Au3+ and Pt2+ to Zn7MT-2. However, it should be pointed out
that these metals are used in the forms of organometallic
complexes in most cases, and their reactivities with Zn7MT-2
could differ from those free metal ions, and therefore their
biological implications need to be further investigated.
Chemical affinity of Hg species towards Zn7MT-2
Hg vapor from amalgam tooth fillings, CH3Hg
+ in fish and
C2H5Hg
+ in the form of C2H5Hg-THI are three of the means of
Hg exposure for billions of people.19 It has already been found
that MTs are important protective factors against the toxicity of
Hg.20,21 For MT-2, it can bind with Hg2+ to form Hg7–MT
(tetrahedral coordination geometry), Hg12–MT (trigonal) and
Hg18–MT (linear) complexes under in vitro conditions,
22 which
provides strong evidence for its use in detoxification in vivo.23
For CH3Hg
+ and C2H5Hg-THI, although there are some studies
focusing on their relationship with MTs or Zn2+ in vivo,24,25
fundamental in vitro information is limited.
Taking CH3Hg
+ as an example, the SEC/ICP-MS results show
that it could gradually replace all the Zn2+ in Zn7MT-2 along
with an increase in the molar ratio (Fig. 3). Besides this,
CH3Hg
+ binding with –SHs destroyed the stereostructure of
the a- and b-domains of the Zn7MT-2 to form unordered linear
(CH3Hg)xMT-2 complexes as indicated by CD spectroscopic
studies (Fig. 4) because CH3Hg
+ bound with –SH in a quasi-
covalent way, and the existence of a methyl group made the
complexes more hydrophobic, thus decreasing its solubility in the
physiological solution and causing the degressive 32S16O intensity
shown in Fig. 3b and c. This provided evidence for the toxicity of
CH3Hg
+ as it could denature the native protein molecule.
In order to further study the structural changes of MT-2
caused by CH3Hg
+, the conformation change of the MT-2
complex during the interaction process was studied using CD
spectroscopy (Fig. 4). Based on the available structural informa-
tion in the PDB database (PDB 1MRB and PDB 2MRB), the
secondary structure of Zn7MT-2 has the same molecular archi-
tecture as Cd7MT-2 containing several half-turns and 310-helix
segments as well as a random coil.26 The CD curve of Zn7MT-2
in Fig. 4 was characterized by (1) a minimum centered at
200 nm, (2) a weak negative shoulder between 220 and
230 nm, and (3) a positive band at 244 nm, which should
correspond to the random coil (1), 310-helix (2) and Zn–thiolate
cluster (3), respectively.27,28 After the addition of CH3Hg
+, the
gradual disappearance observed of this characteristic CD
fingerprint of Zn7MT-2 indicated new unordered structures were
formed as the Zn2+ in the Zn7MT-2 was replaced by CH3Hg
+ and
interaction developed between the MT-2 and CH3Hg
+.
Moreover, the compositions of (CH3Hg)xMT-2 complexes formed
at nCH3Hg+/nMT-2 = 20 were characterized using MALDI-TOF-MS
Fig. 3 SEC/ICP-MS chromatograms of Zn7MT-2 (a), reacting with CH3Hg
+ at
nCH3Hg+/nMT-2 = 1 (b) and 100 (c) at pH 7.4.
Fig. 4 Titration CD spectra of Zn7MT-2 with CH3Hg
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and RP-HPLC/ESI-IT-MS. Because sinapinic acid (pH o 6) was
used as a matrix in the MALDI-TOF-MS, the Zn7MT-2 was
detected mainly as the apo-MT-2 form (* peak in Fig. 5a,
6124.5 Da) although some Zn3MT-2 (6312.1 Da) and Zn7MT-2
(6567.1 Da) could also be observed at the tip positions of the
arrows. In the enlarged figure of Fig. 5a, other subisoforms of
MT-2 could also be observed which was in accordance with the
RP-HPLC/ESI-IT-MS results (Fig. S1d, ESI†). The (CH3Hg)xMT-2
complex (* peak in Fig. 5b) detected is 3799 Da heavier than the
apo-MT-2. The value of x was calculated to be between 17 and 18,
suggesting that (CH3Hg)17MT-2 and (CH3Hg)18MT-2 are the
dominant forms under these experimental conditions, which is
in accordance with the results obtained using RP-HPLC/
ESI-IT-MS (Fig. 6). Other (CH3Hg)xMT-2 complexes (x = 12, 13,
14, 15, 16, 19 and 20) could also be found in much lower
abundance in the same medium (arrow positions in Fig. 5b). As
shown in Fig. 6, (CH3Hg)17MT-2 and (CH3Hg)18MT-2 as well as
(CH3Hg)19MT-2 and (CH3Hg)20MT-2 could be clearly observed,
suggesting their formation. Under the physiological solution
environment conditions (pH 7.4) in this study, continual titra-
tion (nCH3Hg+/nMT-2 4 20) enforced the formation of higher
stoichiometric ratio (CH3Hg)xMT-2 complexes (x 4 18) until a
reaction equilibrium was reached. This is the first report of
mass spectroscopic studies on the interactions of CH3Hg
+ with
Zn7MT-2.
Based on the measured IHg/ISO and IZn/ISO values, the binding
processes of Hg2+, CH3Hg
+ and C2H5Hg-THI with Zn7MT-2 were
compared. Fig. 7a and b show that Zn2+ was continually released
from the Zn7MT-2 molecule as the molar ratio increased until all
theSHs were occupied by Hg2+, CH3Hg+ and the C2H5Hg+ from
C2H5Hg-THI. Compared with CH3Hg
+ and C2H5Hg-THI that
could form R–Hg–S– (R = CH3Hg
+ or C2H5Hg
+) with –SH,29
Hg2+ formed –S–Hg–S– bonds besides –Hg–S– with –SHs, resulting
in a much faster replacement of Zn2+, and exhibited the
strongest affinity towards MT-2 among the three Hg species.
Fig. 5 MALDI-TOF-MS of Zn7MT-2 (a) and CH3Hg–MT-2 complexes (b) formed
after the titration with CH3Hg
+ at nCH3Hg+/nMT-2 = 20.
Fig. 6 RP-HPLC/ESI-IT-MS of CH3Hg–MT-2 complexes formed after the titration of Zn7MT-2 with CH3Hg
+ at nCH3Hg+/nMT-2 = 20.
Fig. 7 Substitution of the Zn2+ in Zn7MT-2 by Hg
2+, CH3Hg
+ and C2H5Hg-THI
(a) and the binding process of the three Hg species with MT-2 (b) at different
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Compared with CH3Hg
+, the C2H5Hg
+ in C2H5Hg-THI had to be
released first before attacking the –SH in Zn7MT-2, leading to
its binding process with the MT-2 being much slower than that
of CH3Hg
+. The C2H5Hg
+ cannot be released from the C2H5Hg-
THI molecule until it approaches another –SH.30 This is why
C2H5Hg-THI has been used in vaccines as a preservative for
many years, and it is less toxic and much safer than the direct
use of CH3Hg
+ or C2H5Hg
+. Similar phenomena whereby intra-
cellular Zn2+ concentration increases after exposure to CH3Hg
+
and/or C2H5Hg-THI have been observed when studying the
toxicity of CH3Hg
+ and/or C2H5Hg-THI in vivo.
31,32 Thus, it can
be concluded that the binding affinities of these Hg species




The chemical affinities and Zn-exchange abilities of three
submetallomes towards Zn7MT-2 were evaluated using SEC/
ICP-MS, in which the S in Zn7MT-2 could serve as a natural
internal standard. The binding properties and processes of
Zn7MT-2 to the metallic species in the submetallomes could
be observed in a physiological solution environment. More
importantly, the interaction of CH3Hg
+ with the MT-2 was
further evaluated using MALDI-TOF-MS and RP-HPLC/ESI-IT-MS
as well as CD spectroscopy, offering valuable information on the
composition and stereostructural change of the CH3Hg–MT-2
complexes. The information obtained is helpful in understanding
the biological functions of metals (especially Hg species) and
metallothioneins. Moreover, it should be expected that SEC/
ICP-MS together with molecular mass spectrometry could be
applied to in vivo studies of the roles of metals and interactions
between the metals and metalloproteins (not limited to Zn7MT-2)
during certain biological life processes in the near future.
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